The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| LFVN | -27.13% | -17.16% | -3.69% | -60% |
| S&P | +15.06% | +95.03% | +14.29% | +490% |
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $55.11M | 12.6% |
| Gross Profit | $44.05M | 13.2% |
| Gross Margin | 79.92% | 0.4% |
| Market Cap | $164.65M | 101.9% |
| Market Cap / Employee | $0.69M | 0.0% |
| Employees | 238 | 7.2% |
| Net Income | $1.96M | 50.1% |
| EBITDA | $2.90M | -22.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $20.20M | 19.6% |
| Accounts Receivable | $3.29M | 11.7% |
| Inventory | 20.7 | 37.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $9.81M | -16.9% |
| Short Term Debt | $1.87M | 3.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 14.83% | 10.2% |
| Return On Invested Capital | 15.88% | -3.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $0.84M | -63.8% |
| Operating Free Cash Flow | $1.03M | -60.0% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 37.80 | 31.02 | 20.88 | 17.53 | -38.52% |
| Price to Book | 5.44 | 7.90 | 6.12 | 4.84 | 59.00% |
| Price to Sales | 0.79 | 1.09 | 0.87 | 0.75 | 82.07% |
| Price to Tangible Book Value | 5.50 | 7.99 | 6.17 | 4.87 | 57.93% |
| Price to Free Cash Flow TTM | 44.49 | 21.14 | 19.45 | 20.35 | -25.82% |
| Enterprise Value to EBITDA | 45.64 | 52.47 | 37.85 | 56.31 | 163.77% |
| Free Cash Flow Yield | 2.2% | 4.7% | 5.1% | 4.9% | 34.80% |
| Return on Equity | 14.5% | 25.7% | 30.1% | 32.3% | 233.89% |
| Total Debt | $13.36M | $12.77M | $12.36M | $11.68M | -14.21% |
LFVN earnings call for the period ending September 30, 2020.
LFVN earnings call for the period ending June 30, 2020.
LFVN earnings call for the period ending March 31, 2020.
LFVN earnings call for the period ending December 31, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
